BIOMAT Database Logo BIOMAT Database Logo

Preparation of antigastric cancer monoclonal antibody MGb2-mitomycin C conjugate with improved antitumor activity. 1990

S Li, and X Y Zhang, and S Y Zhang, and X T Chen, and L J Chen, and Y H Shu, and J L Zhang, and D M Fan
Laboratory of Gastroenterology, Xijing Hospital, Xi'an, Shaanxi Province, China.

In the present study, an antigastric cancer monoclonal antibody, MGb2, was chosen to prepare antibody-mitomycin C conjugate with dextran T-40 as intermediary. Up to 20 molecules of mitomycin C were specifically bound per molecule of antibody, without significantly impairing the antigen-binding capacity of the antibody and the pharmacological activity of mitomycin C. The conjugate showed selective cytotoxicity upon human gastric cancer cell line SGC-7901 in vitro. Radioimmunoimaging and biodistribution studies indicated that, after conjugation with mitomycin C via dextran T-40 as intermediary, the tumor localization capacity of the antibody was well-retained. When tested in nude mice inoculated with human gastric carcinoma GAII in bilateral subrenal capsules, intraperitoneal injection of the conjugate twice a week for 3 weeks at the dose of 1 mg/kg of drug gave a tumor inhibitory rate of 152.29%, the result being far better than that of free mitomycin C or an irrelevant conjugate. A similar result was found in another nude mouse model of human gastric carcinoma SGC-7901. Meanwhile, after conjugation with antibody, the toxicity of mitomycin C on tested animals was significantly reduced.

UI MeSH Term Description Entries
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D008937 Mitomycins A group of methylazirinopyrroloindolediones obtained from certain Streptomyces strains. They are very toxic antibiotics used as ANTINEOPLASTIC AGENTS in some solid tumors. PORFIROMYCIN and MITOMYCIN are the most useful members of the group.
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000922 Immunotoxins Semisynthetic conjugates of various toxic molecules, including RADIOACTIVE ISOTOPES and bacterial or plant toxins, with specific immune substances such as IMMUNOGLOBULINS; MONOCLONAL ANTIBODIES; and ANTIGENS. The antitumor or antiviral immune substance carries the toxin to the tumor or infected cell where the toxin exerts its poisonous effect. Affinotoxin,Antibody-Toxin Conjugate,Antibody-Toxin Conjugates,Antibody-Toxin Hybrid,Antibody-Toxin Hybrids,Chimeric Toxins,Cytotoxin-Antibody Conjugate,Cytotoxin-Antibody Conjugates,Monoclonal Antibody-Toxin Conjugate,Targeted Toxin,Targeted Toxins,Toxin Carriers,Toxin Conjugates,Toxin-Antibody Conjugate,Toxin-Antibody Conjugates,Toxin-Antibody Hybrid,Toxin-Antibody Hybrids,Toxins, Chimeric,Toxins, Targeted,Affinotoxins,Chimeric Toxin,Immunotoxin,Monoclonal Antibody-Toxin Conjugates,Toxin Carrier,Toxin Conjugate,Antibody Toxin Conjugate,Antibody Toxin Conjugates,Antibody Toxin Hybrid,Antibody Toxin Hybrids,Antibody-Toxin Conjugate, Monoclonal,Antibody-Toxin Conjugates, Monoclonal,Carrier, Toxin,Carriers, Toxin,Conjugate, Antibody-Toxin,Conjugate, Cytotoxin-Antibody,Conjugate, Monoclonal Antibody-Toxin,Conjugate, Toxin,Conjugate, Toxin-Antibody,Conjugates, Antibody-Toxin,Conjugates, Cytotoxin-Antibody,Conjugates, Monoclonal Antibody-Toxin,Conjugates, Toxin,Conjugates, Toxin-Antibody,Cytotoxin Antibody Conjugate,Cytotoxin Antibody Conjugates,Hybrid, Antibody-Toxin,Hybrid, Toxin-Antibody,Hybrids, Antibody-Toxin,Hybrids, Toxin-Antibody,Monoclonal Antibody Toxin Conjugate,Monoclonal Antibody Toxin Conjugates,Toxin Antibody Conjugate,Toxin Antibody Conjugates,Toxin Antibody Hybrid,Toxin Antibody Hybrids,Toxin, Chimeric,Toxin, Targeted

Related Publications

S Li, and X Y Zhang, and S Y Zhang, and X T Chen, and L J Chen, and Y H Shu, and J L Zhang, and D M Fan
[The antitumor activity of bovine serum albumin-mediated conjugate of hematoporphyrin derivative with antigastric cancer monoclonal antibody].
January 1990, Yao xue xue bao = Acta pharmaceutica Sinica,
S Li, and X Y Zhang, and S Y Zhang, and X T Chen, and L J Chen, and Y H Shu, and J L Zhang, and D M Fan
Antitumor activity of doxorubicin-monoclonal antibody conjugate on human bladder cancer.
August 1988, The Journal of urology,
S Li, and X Y Zhang, and S Y Zhang, and X T Chen, and L J Chen, and Y H Shu, and J L Zhang, and D M Fan
Tumor localization and in vivo antitumor activity of the immunoconjugate composed of anti-human colon cancer monoclonal antibody and mitomycin C-dextran conjugate.
February 1991, Japanese journal of cancer research : Gann,
S Li, and X Y Zhang, and S Y Zhang, and X T Chen, and L J Chen, and Y H Shu, and J L Zhang, and D M Fan
Antitumor activity of mitomycin C-dextran conjugate against various murine tumors.
April 1981, Gan,
S Li, and X Y Zhang, and S Y Zhang, and X T Chen, and L J Chen, and Y H Shu, and J L Zhang, and D M Fan
Pharmacokinetic characteristics and antitumor activity of the N-succinyl-chitosan-mitomycin C conjugate and the carboxymethyl-chitin-mitomycin C conjugate.
January 1993, Biological & pharmaceutical bulletin,
S Li, and X Y Zhang, and S Y Zhang, and X T Chen, and L J Chen, and Y H Shu, and J L Zhang, and D M Fan
Production of a monoclonal antibody-mitomycin C conjugate, utilizing dextran T-40, and its biological activity.
January 1985, Biochemical pharmacology,
S Li, and X Y Zhang, and S Y Zhang, and X T Chen, and L J Chen, and Y H Shu, and J L Zhang, and D M Fan
[Antitumor activity of new antitumor antibiotic C1027 and its monoclonal antibody assembled conjugate].
January 1992, Yao xue xue bao = Acta pharmaceutica Sinica,
S Li, and X Y Zhang, and S Y Zhang, and X T Chen, and L J Chen, and Y H Shu, and J L Zhang, and D M Fan
Antitumor activity of timed-release derivative of mitomycin C, agarose bead conjugate.
June 1978, Chemical & pharmaceutical bulletin,
S Li, and X Y Zhang, and S Y Zhang, and X T Chen, and L J Chen, and Y H Shu, and J L Zhang, and D M Fan
[Targeting therapy of cancer using monoclonal antibody-antitumor drug conjugate].
June 1989, Nihon rinsho. Japanese journal of clinical medicine,
S Li, and X Y Zhang, and S Y Zhang, and X T Chen, and L J Chen, and Y H Shu, and J L Zhang, and D M Fan
Cellular interaction and in vitro antitumor activity of mitomycin C-dextran conjugate.
September 1986, Cancer research,
Copied contents to your clipboard!